SCHEMBL2527600

SCHEMBL2527600

COc1ccc(-c2ccc3[nH]cc(-c4ccc5[nH]ccc5c4)c3c2)cc1OC

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 5/20 0.73
LRRK2 Q5S007 1/20 0.59
PRKCQ Q04759 4/20 0.55
KIT P10721 7/20 0.53
DYRK1A Q13627 2/20 0.53
KDR P35968 1/20 0.48
PRKCD Q05655 2/20 0.47
PRKCH P24723 1/20 0.47
PRKCE Q02156 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
HCRTR1 O43613 1/20 0.47
CASP3 P42574 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
AAK1 Q2M2I8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2526092 0.89 MAP3K11 (0.60) MAP3K11LRRK2PRKCQKITDYRK1A
SCHEMBL4339872 0.86 MAP3K11 (0.63) MAP3K11LRRK2PRKCQPRKCDPRKCH
SCHEMBL720862 0.85 MAP3K11 (1.00) MAP3K11LRRK2KITDYRK1AAAK1
SCHEMBL2531824 0.81 MAP3K11 (0.56) MAP3K11LRRK2KIT
SCHEMBL2522333 0.81 MAP3K11 (0.80) MAP3K11LRRK2KITDYRK1A
SCHEMBL2526465 0.80 NPC1 (0.71) MAP3K11LRRK2DYRK1ANPC1HCRTR1
SCHEMBL4329785 0.76 KDR (0.70) KITDYRK1AKDRAAK1
SCHEMBL2521439 0.76 MAP3K11 (0.60) MAP3K11KITDYRK1AKDRAAK1
SCHEMBL719706 0.76 MAP3K11 (0.70) MAP3K11LRRK2PRKCQKITDYRK1A
SCHEMBL724259 0.76 MAP3K11 (0.83) MAP3K11LRRK2KITDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379561-A2 MLK INHIBITORS AND METHODS OF USE University Of Rochester (US) 2011-10-26 EP disclosed
WO-2010068483-A2 MLK INHIBITORS AND METHODS OF USE UNIVERSITY OF ROCHESTER (US) 2010-06-17 WO disclosed